Board of Directors

C. David Adair, M.D.
Chairman, Chief Science Officer, and Founder, Glenveigh Medical, LLC

C. David Adair, MD (Chairman and CSO) is a board-certified maternal-fetal medicine specialist and president of Regional Obstetrical Consultants, an MFM practice with over 50 employees and offices in Chattanooga, Tennessee. Dr Adair is Professor and also serves as Vice-Chairman, Obstetrics and Gynecology, University of Tennessee College of Medicine. He has more than 50 publications and more than 20 teaching/research awards, including 4 Best Research Awards for Clinical Obstetrics. Dr Adair received his undergraduate degree in biological sciences at Morehead State University, his medical degree from Marshall University, residency in Obstetrics and Gynecology at the University of Florida Health Science Center, Jacksonville, and fellowship in Maternal-Fetal Medicine at Wake Forest University. He received extern training at Henry Ford Hospital, National Maternity Hospital, Dublin, Ireland, and at the Renal Unit Mass General Hospital.
J. Scott Adams
President and COO, ProAct Health Solutions, Inc.

Scott is a highly experienced senior healthcare executive with over 40 years of business leadership experience. His diverse background in healthcare includes general management, marketing, sales, business development, early stage ventures, acquisitions and joint ventures in the fields of medical: hospital supplies, disposables and devices; sleep apnea, emergency medical transportation services and dental services.

Scott began his career in 1967 at American Hospital Supply Corporation in sales. After two years in the field he was recruited to be one of three people to be in a new corporate business development department. He directed their entry into the dental business and was later promoted to President of the Dental Division.

In 1976 Scott was recruited by Abbott Labs to develop, grow and manage three business units: Anesthesia, IV Pump and IV Administration. Over the next four years he developed three generations of pumps and dedicated disposables and became a leading IV Pump manufacturer in the U.S. Scott identified Sorenson Laboratories as an acquisition candidate and directed its acquisition. In 1980 Scott became President of General Medical, a $425M health care distribution company. In 1990 Scott relocated to California as President of ParaMed Technologies in Mt. View. Two years later, 1992, he joined InnerDyne as President and CEO. Scott was responsible for redirecting InnerDyne from its original business plan which resulted in one of the leading laparoscopic access companies. InnerDyne was acquired by Tyco.

In 1995 Scott became President of Careline, the second largest EMS provider in the U.S. Scott helped to grow Careline to $250 million in revenue, with the company operating in 22 states through the acquisitions of over 30 EMS providers. Careline went public in 1995 and was acquired by Laidlaw Corporation 1996 for an estimated value of $350 million.

In 1997, Scott started Sleep-Solutions as CEO. Through his leadership the company developed a complete testing system to diagnose sleep apnea in a home setting. Sleep-Solutions was the first company to get FDA approval for this indication. Scott holds patents on the base technology and the MediTrack data analysis system. In June 2001, Scott joined Thomas Fogarty, MD as the General Manager of Fogarty Engineering, which developed AAA grafts, heart valves, breast biopsy and anti-restenosis drug delivery catheters. Scott is currently the President and COO of ProAct Health Solutions, Inc.

Scott holds a Bachelors of Science degree in Marketing from Indiana University. He has served on multiple boards and currently serves as a board member of Atlanta Catheter Therapies. Scott was instrumental in the founding of both Revivant and Starion and was instrumental in negotiating their exits in 2009.
David A. Belitz
CEO, The Lupton Company, LLC
Partner, XMi High Growth Development Fund, LLC

David Belitz currently serves as the Chief Executive Officer of The Lupton Company, LLC. The Lupton Company is a family office established from the sale of the Lupton family’s Coca-Cola Bottling Companies. The office has been managing the family’s investments and other affairs since the mid-1980’s. Mr. Belitz joined the Company in 1997 and served as the controller and CFO before officially receiving the CEO title in January of 2012.

Mr. Belitz is also a founding general partner of the Chattanooga Renaissance Fund, LP. The Fund is a $3.16 million angel fund investing in seed and early stage businesses in the Chattanooga area. Mr. Belitz serves on the Board of Directors of ACT, Inc., and AudiencePoint, LLC, two of the Fund’s portfolio companies.

Mr. Belitz is a partner in XMI High Growth Fund, LLC and TNInvestco based in Nashville, TN.

Prior to joining The Lupton Company, Mr. Belitz worked for five years as a tax accountant and business consultant at Burkhart & Company, P.C. During his tenure at Burkhart & Company, Mr. Belitz prepared tax returns for small business clients and their owners, provided tax and business strategy consulting and provided transaction planning services.

Mr. Belitz holds a M.B.A. in Finance from the University of TN at Chattanooga, a MAcc. emphasis in taxation from the University of TN at Knoxville and a B.S. in Accounting and Business Law from the University of TN at Knoxville.

Mr. Belitz is a Certified Public Accountant. He is a member of both the AICPA and TSCPA.
F. Kevin Dye
Vice President of Finance and Operations and Director

Kevin is the CEO and owner of The Dye Group, Inc., a senior management business consulting business focused within the medical device industry. He has 31 years of experience in the industry. Prior to his current position he worked as the President of TEFTEC Corporation, a power wheelchair manufacturer; CEO of GenPhar, Inc., a biotech vaccine company; President of SwampCat, an insecticide repellent start up; and Alphamed, Incorporated, a company that developed and manufactured ambulatory infusion pumps.

Kevin spent 22 years working at C.R. Bard, Inc. Beginning in Accounting, he worked his way up to Controller of Productos Para el Cuidado de la Salud, S.A. de C.V., a Nogales, Sonora, Mexico maquilladora. Halfway through his time at Bard, he switched careers and became Operations Manager for Bard's all-silicone catheter manufacturing facility in Tucson, AZ. He then worked in supply chain management, becoming the Director of Global Logistics for Bard's Peripheral Technologies Division in Covington, GA.

Kevin has a BS in Accounting/Finance from Fairleigh Dickinson University - Madison, NJ.
Paul J. Fitzpatrick
CEO

Paul brings to Advanced Catheter Therapies (ACT) 24 years of diverse, entrepreneurial business and healthcare experience with a proven track record of delivering results. His company, PJ Fitzpatrick Executive Advisory Group, provides interim and fractional C-level and board engagements to early stage and small companies.

Paul’s experience includes serving as Founder, CEO, President, Board Director, COO and EVP. He has completed over 20 M&A transactions with a combined value in excess of $100 million, and has been involved with numerous start-ups, turnarounds, roll-ups and integration of acquired companies with a range of public, private and venture-backed financing. With an in-depth knowledge of medical devices, clinical and patient care services, developing strategic alliances, multi-site and multi-state state operations, education and international recruiting and staffing, Paul brings a rich skill set and knowledge base to his role with ACT.

Prior to joining ACT, Paul was brought in to serve as interim Chief Executive Officer and Director of NeoMatrix, LLC, an early stage medical device company, by the company’s Investment Bank, Waveland Capital Group. He successfully developed a strategic operational and funding plan to turn around Neomatrix and take it from R&D to commercialization. He founded I-Medical Staffing, a U.S.-based healthcare staffing company that sourced, prepared, and employed highly experienced, internationally trained, English-speaking registered nurses for assignments into U.S. healthcare facilities. The company was merged with a large domestic staffing company in 2006.

Prior experience includes serving as Executive Vice President and COO and a start-up team member of Healthcare Innovations, Inc., a rehabilitation services company that was sold to a large, publicly traded company thanks to his efforts. Paul served as Corporate Vice President at Careline, Inc., an emergency medical services rollup company that had two public offerings raising $57 million and $75 million, respectively, and was eventually acquired for $258 million. He has also operated an emergency medical services consulting firm.

Paul is a graduate of the Daniel Freeman Hospital Paramedic School, earning his board certification as a National Registered Paramedic, and holds a degree in paramedic technology from Northeastern University in Boston where he served as an adjunct faculty member for 10 years.